Stock Research: Qiagen

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Qiagen

NYSE:QGEN NL0012169213
94
  • Value
    67
  • Growth
    67
  • Safety
    Safety
    55
  • Combined
    88
  • Sentiment
    81
  • 360° View
    360° View
    94
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Qiagen NV provides Sample to Insight solutions that transform biological samples into molecular insights. The company operates in the biotechnology industry, offering sample and assay technologies, bioinformatics, and automation systems. Qiagen NV is based in the Netherlands. In the last fiscal year, the company had a market cap of $10,276 million, profits of $1,262 million, revenue of $1,978 million, and 5765 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 94 (better than 94% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Qiagen are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Qiagen. The consolidated Value Rank has an attractive rank of 55, which means that the share price of Qiagen is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 55% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 67, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 67. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 81. ...read more

more
Index
DAX 40
Customer Focus EU
Employee Health EU
Moonshot Tech
Sound Pay Europe
MDAX
TecDAX
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
55 59 57 65
Growth
67 14 15 7
Safety
Safety
67 68 43 20
Sentiment
81 6 47 84
360° View
360° View
94 18 20 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
34 36 39 34
Opinions Change
50 11 50 66
Pro Holdings
n/a 23 74 90
Market Pulse
59 34 44 60
Sentiment
81 6 47 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
55 59 57 65
Growth
67 14 15 7
Safety Safety
67 68 43 20
Combined
88 39 18 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
70 76 74 66
Price vs. Earnings (P/E)
20 28 26 46
Price vs. Book (P/B)
64 70 72 73
Dividend Yield
27 1 1 1
Value
55 59 57 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
37 33 20 4
Profit Growth
48 23 26 27
Capital Growth
75 28 37 45
Stock Returns
55 47 33 23
Growth
67 14 15 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
56 53 36 26
Refinancing
39 73 67 49
Liquidity
71 47 42 29
Safety Safety
67 68 43 20

Similar Stocks

Discover high‑ranked alternatives to Qiagen and broaden your portfolio horizons.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Perrigo

NYSE:PRGO
Country: Ireland
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Koninklijke BAM Groep

ENXTAM:BAMNB
Country: Netherlands
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Ipsen

ENXTPA:IPN
Country: France
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.